Die hormonellen Veränderungen im weiblichen Zyklus beeinflussen eine Vielzahl der Körperfunktionen und können spezifische Erkrankungen hervorrufen bzw. deren Symptomatik verstärken. Eine klassische zyklusabhängige Erkrankung ist die Dysmeno…
PURPOSE: Several studies on the quality of life in patients with endometriosis have been performed with conflicting results. This cross-section survey examines the influence of endometriosis on the psychological well-being and the quality o…
PURPOSE: In a series of publications, we had developed the concept that uterine adenomyosis and pelvic endometriosis as well as endometriotic lesions at distant sites of the body share a common pathophysiology with endometriosis constitutin…
STUDY QUESTION: What is the safe and pharmacodynamically active dose range for PDC31 (prostaglandin F2α receptor inhibitor) in patients with primary dysmenorrhea (PD)? SUMMARY ANSWER: The 1 mg/kg/h dose of PDC31 appears to be safe and pote…